<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>developer</PublisherName>
      <JournalTitle>International journal of Information Technology</JournalTitle>
      <PISSN/>
      <EISSN>n</EISSN>
      <Volume-Issue>Volume 38, Number 1</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>Jan-March</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>subject-2</ArticleType>
      <ArticleTitle>In-silico STUDIES OF AMENTOFLAVONE AND ITS DERIVATIVES AGAINST SARS-COV-2</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>77</FirstPage>
      <LastPage>88</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Faisal Maulana Ibrahim1</FirstName>
          <LastName/>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Holis Abdul</FirstName>
          <LastName>Holik1</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>? and Arifudin</FirstName>
          <LastName>Achmad2</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>The COVID-19 pandemic caused by SARS-CoV-2 infection is of global concern. The SARS-CoV-2 main protease (Mpro2, PDB ID: 6LU7), is an important SARS-CoV-2 enzyme in mediating viral replication and transcription, making it very strategic to be a drug target. Amentoflavone and its derivatives underwent molecular docking and 3D liganbased pharmacophore modeling to analyze their molecular interactions against Mpro2 and evaluation for their absorption, distribution, metabolism, excretion, (ADME) properties. Fifty-one compounds had better docking parameters than comparison compound (remdesivir) and S29 is the best-docked compound (__ampersandsignDelta;G= -13.06 kcal/mol). Amentoflavone derivatives are promising candidates for novel anti-COVID agents.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>: COVID-19, SARS-CoV-2, Amentoflavone, Molecular Docking, In-silico</Keywords>
      <URLs>
        <Abstract>https://developer.ubipayroll.com/ubijournal-v1copy/journals/abstract.php?article_id=13125&amp;title=In-silico STUDIES OF AMENTOFLAVONE AND ITS DERIVATIVES AGAINST SARS-COV-2</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>1. WHO, Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update, World Health Organization (2020), Press Release: 21 April 2021, Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports&#13;
&#13;
2. WHO, Draft landscape of COVID-19 Candidate Vaccines, World Health Organization (2020), Press Release: 3 September 2020, Available at: https://www.who.int/publications/m/item/draft-landscape-ofcovid-19-candidate-vaccines&#13;
&#13;
3. Stephanie Nebehay, Emma Farge, and (Reuters), Widespread COVID-19 Vaccinations not expected until mid-2021, WHO says, World News, Geneva, September 4, 2020(2020), Available at: https://www.reuters.com/article/us-health-coronavirus-who-briefing/widespread-covid-vaccinationsnot-expected-until-mid-2021-who-says-idUSKBN25V1B0&#13;
&#13;
4. Y. Jin, H. Yang, W. Ji, W. Wu, S. Chen, W. Zhang, and G. Duan, Viruses 12, 372(2020), https://doi.org/10.3390/v12040372&#13;
&#13;
5. Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, B. Zhang, X. Li, L. Zhang, and C. Peng, Nature, 582, 1(2020), https://doi.org/10.1038/s41586-020-2223-y&#13;
&#13;
6. P. Eleftheriou, D. Amanatidou, A. Petrou, and A. Geronikaki, Molecules 25, 2529(2020), https://doi.org/10.3390/molecules25112529&#13;
&#13;
7. M. S. Smyth and J. H. Martin, Molecular Pathology 53, 8(2000), https://doi.org/10.1136/mp.53.1.8&#13;
&#13;
8. G. U. Jeong, H. Song, G. Y. Yoon, D. Kim, and Y.-C. Kwon, Frontiers in Microbiology, 11, 1723 (2020), https://doi.org/10.3389/fmicb.2020.01723&#13;
&#13;
9. S. J. Tzotzos, B. Fischer, H. Fischer, and M. Zeitlinger, Critical Care, 24, 516(2020), https://doi.org/10.1186/s13054-020-03240-7&#13;
&#13;
10. WHO, “Solidarity” clinical trial for COVID-19 treatments, World Health Organization (2020), Press Release: July 6, 2020. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19- treatments&#13;
&#13;
11. G. Ragia and V. G. Manolopoulos, European Journal of Clinical Pharmacology, 76,1623(2020), https://doi.org/10.1007/s00228-020-02963-4&#13;
&#13;
12. C. Monari, V. Gentile, C. Camaioni, G. Marino, N. Coppola, and V. COVID, Life 10, 146(2020), https://doi.org/10.3390/life10080146&#13;
&#13;
13. S. Yu, H. Yan, L. Zhang, M. Shan, P. Chen, A. Ding, and S. F. Y. Li, Molecules: A Journal of Synthetic Chemistry and Natural Product Chemistry, 22, 299(2017), https://doi.org/10.3390/molecules22020299&#13;
&#13;
14. Y. B. Ryu, H. J. Jeong, J. H. Kim, Y. M. Kim, J. Y. Park, D. Kim, T. T. Nguyen, S. J. Park, J. S. Chang, K. H. Park, M. C. Rho, and W. S. Lee, Bioorganic and; Medicinal Chemistry, 18, 7940 (2010), https://doi.org/10.1016/j.bmc.2010.09.035&#13;
&#13;
15. C. R. P. Cardoso, I. M. d. S. Cand;oacute;lus, C. C. Bernardi, M. Sannomiya, W. Vilegas, and E. A. Varanda, Toxicology 225, 55 (2006), https://doi.org/10.1016/j.tox.2006.05.003&#13;
&#13;
16. C. A. Lipinski, Drug Disco&#13;
&#13;
17. M. Bzowka, K. Mitusinska, A. Raczynska, A. Samol, J. A. Tuszynski, and A. Gora, International Journal of Molecular Sciences, 21, 3099 (2020), https://doi.org/10.3390/ijms21093099&#13;
&#13;
18. M. Vieth, M. G. Siegel, R. E. Higgs, I. A. Watson, D. H. Robertson, K. A. Savin, G. L. Durst, and P. A. Hipskind, Journal of Medicinal Chemistry, 47, 224 (2004), https://doi.org/10.1021/jm030267j&#13;
&#13;
19. A. Puratchikody, D. Sriram, A. Umamaheswari, and N. Irfan, Chemistry Central Journal, 10, 24 (2016), https://doi.org/10.1186/s13065-016-0169-9&#13;
&#13;
20. A. Tronde, B. Norden, H. Marchner, A. K. Wendel, H. Lennernas, and U. H. Bengtsson, Journal of Pharmaceutical Sciences, 92, 1216 (2003), https://doi.org/10.1002/jps.10386&#13;
&#13;
21. G. A. Jeffrey, "An introduction to hydrogen bonding." Oxford University Press, New York, (1997), https://doi.org/10.1021/ja9756331&#13;
&#13;
22. M. Wieder, U. Perricone, T. Seidel, S. Boresch, and T. Langer, Monatshefte fand;uuml;r Chemie/Chemical Monthly, 147, 553 (2016), https://doi.org/10.1007/s00706-016-1674-1&#13;
&#13;
23. T. S. Carpenter, D. A. Kirshner, E. Y. Lau, S. E. Wong, J. P. Nilmeier, and F. C. Lightstone, Biophysical Journal, 107, 630 (2014), https://doi.org/10.1016/j.bpj.2014.06.024&#13;
&#13;
24. W. E. Lindup and M. C. Orme, British Medical Journal (Clinical Research Edition), 282, 212(1981), https://doi.org/10.1136/bmj.282.6259.212&#13;
&#13;
25. O. O. Olubiyi, M. Olagunju, M. Keutmann, J. Loschwitz, and B. Strodel, Molecules, 25 (2020), https://doi.org/10.3390/molecules25143193&#13;
&#13;
26. L. Peterson, COVID-19 and Flavonoids: In-silico Molecular Dynamics Docking to the Active Catalytic Site of SARS-CoV and SARS-CoV-2 Main Protease, Social Science Research Network(2020), Available at: https://chemrxiv.org/articles/preprint/In_Silico_Molecular_Dynamics_Docking_of_Drugs_to_the_Inh ibitory_Active_Site_of_SARS-CoV2_Protease_and_Their_Predicted_Toxicology_and_ADME/12155523&#13;
&#13;
27. A. Mishra, Y. Pathak, G. Choudhir, A. Kumar, S. K. Mishra, and V. Tripathi, Research Square(22 June, 2020)(2020), Available at: https://www.researchsquare.com/article/rs-22839/v2.pdf&#13;
&#13;
28. S. T. Ngo, N. Quynh Anh Pham, L. Thi Le, D.-H. Pham, and V. V. Vu, Journal of Chemical Information and modeling, (epub date: June 12) (2020), https://doi.org/10.1021/acs.jcim.0c00491&#13;
&#13;
29. M. Kateryna and V. S. Anna, ChemRXiv(epub date: 29 May 2020)(2020), Available at: https://chemrxiv.org/articles/preprint/Combined_Use_of_Amentoflavone_and_Ledipasvir_Could_Int erfere_with_Binding_of_Spike_Glycoprotein_of_SARS-CoV2_to_ACE2_The_Results_of_Molecular_Docking_Study/12377870&#13;
&#13;
30. S. Megantara, J. Levita, S. Ibrahim, and B. P. Nguyen, Rasayan Journal of Chemistry, 14(2020), https://doi.org/10.31788/RJC.2021.1416070&#13;
&#13;
31. S. S. Murthy, T. B. Narsaiah, Rasayan Journal of Chemistry, 4(2019), https://doi.org/10.31788/RJC.2019.1245475&#13;
&#13;
32. M. Muchtaridi, D. Dermawan, M. Yusuf, Journal of Young Pharmacists, 10(3), 253(2018), https://doi.org/10.5530/jyp.2018.10.58&#13;
&#13;
33. M. Muchtaridi, S. Megantara, D. Dermawan, M. Yusuf, Rasayan Journal of Chemistry, 12(2019), https://doi.org/10.31788/RJC.2019.1245391</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>